A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
CAMBRIDGE, Mass., Sept. 30, 2025 /PRNewswire/ -- Clear Scientific Inc., a clinical stage biopharmaceutical company focused on the development of first-in-class small molecules to reverse acute ...
Methamphetamine use , methamphetamine-related overdoses, and methamphetamine use disorder (MUD) are national problems that cause serious illness and death.. Making matters worse, methamphetamine is ...
Idaho feels removed from the headlines about drug overdoses that dominate coverage of coastal cities and struggling rust belt ...
BALTIMORE (The Baltimore Sun) — Methamphetamine intoxication caused the death of an Idaho hospital executive whose body was found in a downtown Baltimore hotel in June, the state medical examiner’s ...